329 related articles for article (PubMed ID: 9601875)
1. [Favorable effect of splenectomy on anemia in 3 siblings with type II congenital dyserythropoietic anemia (HEMPAS). (Ultrastructural changes in erythrocytes after splenectomy)].
Chrobák L; Spacek J
Vnitr Lek; 1997 Oct; 43(10):635-8. PubMed ID: 9601875
[TBL] [Abstract][Full Text] [Related]
2. Congenital dyserytropoietic anaemia, type II (HEMPAS) in three siblings.
Chrobák L; Radochová D; Smetana K; Matĕja F; Kout M; Polák J; Dítĕ P; Pribroský J; Dvorácková I
Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(4):628-40. PubMed ID: 6162730
[TBL] [Abstract][Full Text] [Related]
3. Excess of Pappenheimer bodies (siderocytes) in two splenectomized siblings with congenital dyserythropoietic anemia--type II (CDA-II) and iron overload.
Chrobák L; Matysová J
Acta Medica (Hradec Kralove); 2004; 47(3):187-8. PubMed ID: 15568737
[TBL] [Abstract][Full Text] [Related]
4. [Congenital dyserythropoietic anemia--type II (CDA-II) in 3 siblings with long-term follow up and iron overload].
Chrobák L; Hůlek P; Nozicka J
Acta Medica (Hradec Kralove) Suppl; 2004; 47(1):29-33. PubMed ID: 15745056
[TBL] [Abstract][Full Text] [Related]
5. A family with congenital dyserythropoietic anemia type II (HEMPAS).
Omine M; Yamauchi H; Nogiwa E; Umegae S; Tsuchiya J; Maekawa T
Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):1-15. PubMed ID: 7315134
[No Abstract] [Full Text] [Related]
6. Reduced deformability of erythrocytes as feature of congenital dyserythropoietic anaemia type II (HEMPAS).
Izzo P; Spagnuolo A; Manicone A; Nazzaro P; Lauta VM
Clin Hemorheol Microcirc; 1999; 21(3-4):425-30. PubMed ID: 10711781
[TBL] [Abstract][Full Text] [Related]
7. [Anemia caused by congenital dyserythropoiesis: type II (Hempas). Value of splenectomy].
Sondag D; Weill JP; Oberling F
Nouv Presse Med; 1982 Jul 10-17; 11(32):2419. PubMed ID: 7111012
[No Abstract] [Full Text] [Related]
8. Congenital dyserythropoietic anemia type II: serologic and morphologic family study.
Ricci P; Baccarani M; Biagini G; Preda P; Tomasini I; Zucchelli P; Tura S
Nouv Rev Fr Hematol (1978); 1979; 21(2):197-207. PubMed ID: 514807
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of iron overload with phlebotomies in two siblings with congenital dyserythropoietic anemia--type II (CDA-II).
Chrobák L
Acta Medica (Hradec Kralove); 2006; 49(3):193-5. PubMed ID: 17117609
[TBL] [Abstract][Full Text] [Related]
10. [Morphological studies of erythrocytes in congenital dyserythropoietic anemia type II].
Koehler M; Schmidt-Riese L; Brandeis WE
Acta Haematol Pol; 1990; 21(2):144-52. PubMed ID: 2131714
[TBL] [Abstract][Full Text] [Related]
11. Abnormal lipid composition of the red cell membrane in congenital dyserythropoietic anemia type II (HEMPAS).
Joseph KC; Gockerman JP; Alving CR
J Lab Clin Med; 1975 Jan; 85(1):34-40. PubMed ID: 1141728
[TBL] [Abstract][Full Text] [Related]
12. Hairy cell leukemia associated with congenital dyserythropoietic anemia type II (HEMPAS).
Marisavljevic D; Rolovic Z; Vuckovic S; Gotic M; Jovanovic V
Haematologia (Budap); 1994; 26(1):39-43. PubMed ID: 7959373
[TBL] [Abstract][Full Text] [Related]
13. Advances in the understanding of the congenital dyserythropoietic anaemias.
Wickramasinghe SN; Wood WG
Br J Haematol; 2005 Nov; 131(4):431-46. PubMed ID: 16281933
[TBL] [Abstract][Full Text] [Related]
14. A case of congenital dyserythropoietic anemia type II (HEMPAS).
Moriwaki Y; Matsui K; Fujioka H; Iwahashi N; Seno T; Tamura S; Yamamoto T; Amuro Y; Hada T; Higashino K
Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):29-36. PubMed ID: 4003011
[No Abstract] [Full Text] [Related]
15. Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects.
Iolascon A; D'Agostaro G; Perrotta S; Izzo P; Tavano R; Miraglia del Giudice B
Haematologica; 1996; 81(6):543-59. PubMed ID: 9009444
[TBL] [Abstract][Full Text] [Related]
16. Congenital dyserythropoietic anaemia (CDA) type I--a case report with ultrastructural study.
Ghosh K; Mohanty D; Bhagwat AG; Das KC
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):716-22. PubMed ID: 2416648
[TBL] [Abstract][Full Text] [Related]
17. Successful management of congenital dyserythropoietic anemia type I with interferon alpha in a child.
Yarali N; Fişgin T; Duru F; Atilla P; Müftüoğlu SF; Kaymaz SF
Pediatr Hematol Oncol; 2005 Jun; 22(4):265-70. PubMed ID: 16020112
[TBL] [Abstract][Full Text] [Related]
18. Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis.
Heimpel H
Ann Hematol; 2004 Oct; 83(10):613-21. PubMed ID: 15278299
[TBL] [Abstract][Full Text] [Related]
19. Circulating nucleated red blood cells following splenectomy in a patient with congenital dyserythropoietic anemia.
Adams CD; Kessler JF
Am J Hematol; 1991 Oct; 38(2):120-3. PubMed ID: 1951301
[TBL] [Abstract][Full Text] [Related]
20. Natural history of congenital dyserythropoietic anemia type II.
Iolascon A; Delaunay J; Wickramasinghe SN; Perrotta S; Gigante M; Camaschella C
Blood; 2001 Aug; 98(4):1258-60. PubMed ID: 11493480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
